SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-059183
Filing Date
2020-03-02
Accepted
2020-03-02 17:15:37
Documents
3
Period of Report
2020-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d872623d8k.htm 8-K 29249
2 EX-2.1 d872623dex21.htm EX-2.1 360820
3 EX-99.1 d872623dex991.htm EX-99.1 129464
  Complete submission text file 0001193125-20-059183.txt   520755
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 20678228
SIC: 2834 Pharmaceutical Preparations